To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…

Ended Definitive Contract Awarded Last action

Contract number
75N93020C00004
Awardee
Awarding agency
Obligated
$6,337,599

Award facts

Opportunity
Contract value 100% obligated
$6,337,599.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Chicago, IL 60611, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00021 -$96,749
Other Administrative Action P00020 -$2
Other Administrative Action P00019 $0
Other Administrative Action P00018 $0
Other Administrative Action P00017 $0
Other Administrative Action P00016 $0
Other Administrative Action P00015 · Ermes evaluation of radiomitigative efficacy and safety of BP-C2 $0
Other Administrative Action P00014 $0
Other Administrative Action P00013 · IPP: ermes evaluation of radiomitigative efficacy and safety of BP-C2 $0
Funding Only Action P00012 $39,000
Funding Only Action P00011 $27,233
Other Administrative Action P00010 $0
Exercise an Option P00009 $1,969,140
Other Administrative Action P00008 $0
Other Administrative Action P00007 $405,645
Other Administrative Action P00006 $100,000
Exercise an Option P00005 $1,933,102
Other Administrative Action P00004 · Ermes evaluation of radiomitigative efficacy and safety of BP-C2 $0
Other Administrative Action P00003 · Ermes evaluation of radiomitigative efficacy and safety of BP-C2 edited by PATELAP2_NIH on 02/12/2021 16:24:29 edited by PATELAP2_NIH on 02/12/2021 16:24:40 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award Ermes evaluation of radiomitigative efficacy and safety of BP-C2 $1,960,230
Show all 22

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Meabco Inc. for evaluation of radiomitigative efficacy and safety of BP-C2, a medical countermeasure for radiation injury, with a ceiling value of $6,337,599.34 and an award date of May 1, 2020. The contract is cost-plus-fixed-fee and carries no set-aside.

The originating solicitation was a Broad Agency Announcement seeking proposals to develop safe and effective medical countermeasures to mitigate and treat tissue injuries from ionizing radiation exposure in radiological or nuclear incidents. The goal was to fund one to two awards of up to $4 million per year to support research and development of countermeasures that can treat radiation injuries occurring 24 hours or later after exposure, reducing radiation-associated morbidities and mortalities when strategic national stockpile drugs may not be mobilized immediately.

Place of performance is Chicago, IL. The ultimate completion date was April 30, 2025. The contract is currently in de-obligation status to expend remaining fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) before the September 30, 2026 close of that fiscal year's period of availability.

Meabco Inc. reported government-invoiced labor totaling $1.4 million in FY2021 (2.7 FTEs, 5,698 hours), scaling to $4.1 million in FY2024 (0.7 FTEs, 1,419 hours). Derived hourly rates rose from $240.92 in FY2021 to $2,911.89 in FY2024, reflecting a narrowed labor footprint in final performance years.

Description

As the agency reported it.

To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.

Quick answers

Who was awarded contract 75N93020C00004?

75N93020C00004 was awarded to Meabco Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2020.

How much is contract 75N93020C00004 worth?

The government has obligated $6,337,599 on 75N93020C00004.

Was contract 75N93020C00004 competed?

The extent of competition for 75N93020C00004 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login